SCHEMBL1383155

SCHEMBL1383155

O=C(C=Cc1ccc(C(=O)N2CCSCC2)cc1)c1nc2ccccc2nc1O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 6/20 0.43
ALDH1A1 P00352 2/20 0.43
HSD17B10 Q99714 1/20 0.43
KDM4E B2RXH2 1/20 0.43
RAB9A P51151 1/20 0.43
GPR183 P32249 6/20 0.41
APP P05067 4/20 0.40
GRM5 P41594 1/20 0.39
BMPR1B O00238 1/20 0.39
PLK4 O00444 1/20 0.39
STK25 O00506 1/20 0.39
CIT O14578 1/20 0.39
RIOK3 O14730 1/20 0.39
CHEK1 O14757 1/20 0.39
IKBKB O14920 1/20 0.39
AURKA O14965 1/20 0.39
GAK O14976 1/20 0.39
DCLK1 O15075 1/20 0.39
CHUK O15111 1/20 0.39
MUSK O15146 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1383947 0.87 APP (0.52) HPGDALDH1A1HSD17B10KDM4ERAB9A
SCHEMBL5095604 0.87 APP (0.53) HPGDALDH1A1GPR183APPGRM5
SCHEMBL1382357 0.83 SMN1; SMN2 (0.47) ALDH1A1HSD17B10KDM4E
SCHEMBL5101859 0.82 HPGD (0.45) HPGDALDH1A1HSD17B10KDM4ERAB9A
SCHEMBL1384984 0.82 PTK2 (0.50) HPGDALDH1A1HSD17B10KDM4ERAB9A
SCHEMBL1383574 0.80 TSHR (0.45) HPGDALDH1A1HSD17B10KDM4ERAB9A
SCHEMBL1383157 0.80 SMN1; SMN2 (0.48) ALDH1A1
SCHEMBL1382578 0.80 DRD2 (0.49) RAB9AGPR183
SCHEMBL1386812 0.78 ALDH1A1 (0.51) HPGDALDH1A1RAB9A
SCHEMBL1386346 0.77 ELANE (0.41) ALDH1A1KDM4ERAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4790704-B2 2011-10-12 JP claimed
US-20080207608-A1 2-Propene-1-Ones As Hsp 70 Inducers TORRENT PHARMACEUTICALS LTD. (IN) 2008-08-28 US claimed
EP-1748987-A2 2-PROPENE-1-ONES AS HSP 70 INDUCERS Torrent Pharmaceuticals Ltd (IN) 2007-02-07 EP claimed
WO-2005097746-A2 2-PROPENE-1-ONES AS HSP 70 INDUCERS TORRENT PHARMACEUTICALS LTD (IN) 2005-10-20 WO claimed
US-20080207608-A1 2-Propene-1-Ones As Hsp 70 Inducers TORRENT PHARMACEUTICALS LTD. (IN) 2008-08-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080207608-A1 2-Propene-1-Ones As Hsp 70 Inducers HSPB1, HSF1, HSPE1 HPGD 314/4885ALDH1A1 1129/4885HSD17B10 1274/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.